OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial

Yuan‐Yuan Cheng, R Yang, J. Chen, W. Zhang, Chunguang Xie, Qing Hu, Ningning Zhou, Cibo Huang, Sheng Wei, Huaibo Sun, Xiaofei Li, Yan Yu, Jianbo Lai, Hua Yang, Honggang Fang, Hui Chen, Pengfei Zhang, Kangsheng Gu, Qi Wang, Jingyun Shi, T. Yi, Xiaojiang Xu, Xianjiang Ye, Dan Wang, Chunguang Xie, Changxu Liu, Yixi Zheng, Daniel Lin, Wenyi Zhuang, Ping Lu, Guohua Yu, Jun Li, Ying Gu, B. Li, Rong Wu, Ou Jiang, Zhaoguang Wang, Gang Wu, Hao Lin, Diansheng Zhong, Yadong Xu, Yongqian Shu, Donghai Wu, X. Chen, Jun Wang, M. Wang